Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1993;1(1):32–36. doi: 10.1155/S1064744993000080

Clinical Significance of Credé's Prophylaxis in Germany at Present

Udo B Hoyme 1,2
PMCID: PMC2364679  PMID: 18476203

Abstract

The introduction of silver nitrate for prophylaxis of gonococcal ophthalmia neonatorum is one of the milestones of preventive medicine. However, in our time an increasing necessity to review Credé's prophylaxis from both a human rights and a medical standpoint is required. The chairmen of the obstetrics and gynecology departments of the German university hospitals were questioned to learn about their policy and experience. Data were provided by 22 of 28 consulted institutions, representing 31,700 annual deliveries seen over a mean period of 5.5 years. Ocular prophylaxis was in use in 16 (73%) of the reporting hospitals (1% silver nitrate in 14 and gentamicin in 2). A nonspecific conjunctival reaction occurred in 5–10% of the newborns, but no major side effects were seen. Non-gonococcal ophthalmia neonatorum was observed in less than 0.1%; however, institutions without a preventive policy reported up to a 5% incidence of neonatal conjunctivitis, mostly due to Staphylococcus aureus, as well as Neisseria gonorrhoeae in two newborns. Application of silver nitrate is considered a necessary prophylactic measure and safe if it is properly administered. However, major efforts should be directed toward its replacement by alternative antiseptic substances as well as toward chlamydial screening and therapy in pregnancy.

Full Text

The Full Text of this article is available as a PDF (422.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein G. A., Davis J. P., Katcher M. L. Prophylaxis of neonatal conjunctivitis. An analytic review. Clin Pediatr (Phila) 1982 Sep;21(9):545–550. doi: 10.1177/000992288202100906. [DOI] [PubMed] [Google Scholar]
  2. Black-Payne C., Bocchini J. A., Jr, Cedotal C. Failure of erythromycin ointment for postnatal ocular prophylaxis of chlamydial conjunctivitis. Pediatr Infect Dis J. 1989 Aug;8(8):491–495. doi: 10.1097/00006454-198908000-00003. [DOI] [PubMed] [Google Scholar]
  3. Bryant B. G. Unit dose erythromycin ophthalmic ointment for neonatal ocular prophylaxis. JOGN Nurs. 1984 Mar-Apr;13(2):83–87. doi: 10.1111/j.1552-6909.1984.tb01115.x. [DOI] [PubMed] [Google Scholar]
  4. Butterfield P. M., Emde R. N., Svejda M. J. Does the early application of silver nitrate impair maternal attachment? Pediatrics. 1981 May;67(5):737–738. [PubMed] [Google Scholar]
  5. CHRISTIAN J. R. Comparison of ocular reactions with the use of silver nitrate and erythromycin ointment in ophthalmia neonatorum prophylaxis. J Pediatr. 1960 Jul;57:55–60. doi: 10.1016/s0022-3476(60)80210-7. [DOI] [PubMed] [Google Scholar]
  6. Centers for Disease Control (CDC) 1989 Sexually Transmitted Diseases Treatment Guidelines. MMWR Suppl. 1989 Sep 1;38(8):1–43. [PubMed] [Google Scholar]
  7. Chandler J. W. Controversies in ocular prophylaxis of newborns. Arch Ophthalmol. 1989 Jun;107(6):814–815. doi: 10.1001/archopht.1989.01070010836023. [DOI] [PubMed] [Google Scholar]
  8. Fransen L., Van den Berghe P., Mertens A., Van Brussel K., Clara R., Piot P. Incidence and bacterial aetiology of neonatal conjunctivitis. Eur J Pediatr. 1987 Mar;146(2):152–155. doi: 10.1007/BF02343222. [DOI] [PubMed] [Google Scholar]
  9. Giffin R. B., Jr Eye damage in newborns from use of strong silver nitrate solutions. Calif Med. 1967 Aug;107(2):178–181. [PMC free article] [PubMed] [Google Scholar]
  10. Hammerschlag M. R. Neonatal ocular prophylaxis. Pediatr Infect Dis J. 1988 Feb;7(2):81–82. doi: 10.1097/00006454-198802000-00001. [DOI] [PubMed] [Google Scholar]
  11. Hedberg K., Ristinen T. L., Soler J. T., White K. E., Hedberg C. W., Osterholm M. T., MacDonald K. L. Outbreak of erythromycin-resistant staphylococcal conjunctivitis in a newborn nursery. Pediatr Infect Dis J. 1990 Apr;9(4):268–273. doi: 10.1097/00006454-199004000-00009. [DOI] [PubMed] [Google Scholar]
  12. Huber-Spitzy V., Arocker W., Schmidt C. Ophthalmia neonatorum. Klin Monbl Augenheilkd. 1987 Nov;191(5):341–343. doi: 10.1055/s-2008-1050522. [DOI] [PubMed] [Google Scholar]
  13. Isenberg S. J., Apt L., Yoshimori R., McCarty J. W., Alvarez S. R. Source of the conjunctival bacterial flora at birth and implications for ophthalmia neonatorum prophylaxis. Am J Ophthalmol. 1988 Oct 15;106(4):458–462. doi: 10.1016/0002-9394(88)90883-5. [DOI] [PubMed] [Google Scholar]
  14. Laga M., Meheus A., Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ. 1989;67(5):471–477. [PMC free article] [PubMed] [Google Scholar]
  15. Latif A., Mason P., Marowa E., Paraiwa E., Dhamu F., Tambo J., Gwanzura L., Mapeta D., Jongeling G. Management of gonococcal ophthalmia neonatorum with single-dose kanamycin and ocular irrigation with saline. Sex Transm Dis. 1988 Apr-Jun;15(2):108–109. doi: 10.1097/00007435-198804000-00008. [DOI] [PubMed] [Google Scholar]
  16. Lund R. J., Kibel M. A., Knight G. J., van der Elst C. Prophylaxis against gonococcal ophthalmia neonatorum. A prospective study. S Afr Med J. 1987 Nov 7;72(9):620–622. [PubMed] [Google Scholar]
  17. Nishida H., Risemberg H. M. Silver nitrate ophthalmic solution and chemical conjunctivities. Pediatrics. 1975 Sep;56(3):368–373. [PubMed] [Google Scholar]
  18. Rothenberg R. Ophthalmia neonatorum due to neisseria gonorrhoeae: prevention and treatment. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):187–191. doi: 10.1097/00007435-197904000-00027. [DOI] [PubMed] [Google Scholar]
  19. Schirner G., Schrage N. F., Salla S., Teping C., Reim M., Burchard W. G., Schwab B. Corneal silver deposits following Crede's prophylaxis an examination with electron dispersive x-ray analysis (EDX-analysis) and scanning electron microscope (SEM). Lens Eye Toxic Res. 1990;7(3-4):445–457. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES